Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGynecology Physician in Boston, MA
NPI: 1316246549Primary Practice Location
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis St, Boston, MA
Primary Employer
Brigham & Womens Physicians Organization Inc
brighamandwomens.org
HQ Phone
Get M.D. Michelle's Phone Numberphone_androidMobile
Get M.D. Michelle's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardSC State Medical License
MA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 78 | 106 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 42 | 42 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 25 | 32 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 24 | 31 |
| 5 | 58571Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | 19 | 19 |
Authors: Jaclyn Watkins, Ross Berkowitz, Roni Wilke
Journal: Int J Gynecol Cancer
Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.
Authors: Elizabeth Stover, Panagiotis Konstantinopoulos, Allison Kurian, Sara Tolaney, Ann Partridge
Publication Date: 2023-12-07
Authors: Esther Chung, Paula Brady, Elizabeth Ginsburg
Journal: Anticancer Res
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology, Canadian Cancer Trials Group
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, OTHER: Quality-of-Life Assessment, DRUG: Paclitaxel, OTHER: Placebo Administration, PROCEDURE: Computed Tomography
